96. Crohn disease Clinical trials / Disease details

Clinical trials : 2,400 / Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00495521 (ClinicalTrials.gov)	June 2007	29/6/2007	High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children	A Prospective Randomized Double-Blind Study of PASER® in the Management of Patients Experiencing an Acute Flare of Crohn's Disease	Crohn's Disease	Drug: 4-Aminosalicylic acid extended release granules	Jacobus Pharmaceutical	NULL	Terminated	2 Years	18 Years	All	2	Phase 2	United States;Israel
2	NCT00417690 (ClinicalTrials.gov)	January 2007	2/1/2007	High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease	A Prospective Randomized Double-Blind Study of PASER® in the Management of Patients Experiencing an Acute Flare of Crohn's Disease	Crohn's Disease	Drug: 4-Aminosalicylic acid;Drug: PASER placebo granules	Jacobus Pharmaceutical	NULL	Terminated	18 Years	65 Years	Both	54	Phase 2	United States;Israel
3	NCT00004423 (ClinicalTrials.gov)	December 1995	18/10/1999	Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease		Crohn's Disease	Drug: -aminosalicylic acid	University of Vermont	NULL	Completed	18 Years	80 Years	Both	80	N/A	NULL